Addressing consumer grievances in medicine: Policies and practices of newborn screening programs in the United States

Genetic Testing

Volumn 6, Issue 1, 2002, Pages 31-38

  Natowicz, Marvin R ^a   Hiller, Elaine H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATTITUDE; CONSUMER; GENETIC SCREENING; HEALTH CARE POLICY; HUMAN; LAW; NEWBORN SCREENING; PRACTICE GUIDELINE; UNITED STATES; NEWBORN; POLICY; PUBLIC OPINION; QUESTIONNAIRE;

CONSUMER PARTICIPATION; CONSUMER SATISFACTION; GENETIC SCREENING; HUMAN; INFANT, NEWBORN; PUBLIC OPINION; PUBLIC POLICY; QUESTIONNAIRES; UNITED STATES; HUMANS;

EID: 0036016988     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065702760093898     Document Type: Article

References (47)

1. Patients’ rights in managed care-exit, voice, and choice
2. A seat at the table: Membership in federal advisory committees evaluating public policy in genetics
3. Social control of science and technology
4. The doctor-patient relationship and malpractice: Lessons from plaintiff depositions
5. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard medical practice study
6. Patient perception of involvement in medical care: Relationship to illness attitudes and outcomes
7. Quality of health care. Part 2: Measuring quality of care
8. Preventing AIDS, targeting women
9. The increasing importance of patient surveys
10. Patient satisfaction as an indicator of quality care
11. Using patient reports to assess hospital treatment of persons with AIDS: A pilot study
12. Paternalism or partnership?
13. What information do consumers want and need? A synthesis of research to date, plus interviews with health plan managers and consumer advocates
14. The construction of lay expertise: Aids activism and the forging of credibility in the reform of clinical trials
15. Management of patient grievances based on HCFA and Joint Commission rules
16. Patients’ participation in medical care: Effects on blood sugar control and quality of life in diabetes
17. What patients like about their medical care and how often they are asked: A meta-analysis of the satisfaction literature
18. Information and the new movements for citizen participation
19. Facing our mistakes
20. Public participation in medical policy-making and the status of consumer autonomy: The example of newborn-screening programs in the United States
21. Public participation in genetic policy making: The Maryland Commission on hereditary disorders
22. Assessing the effects of physician-patient interactions on the outcomes of chronic disease
23. The past as prologue: Race, class, and gene discrimination
24. The place of the public in the conduct of science
25. The nature of adverse events in hospitalized patients: Results of the Harvard medical practice study II
26. Relation between malpractice claims and adverse events due to negligence: Results of the Harvard medical practice study III
27. Science and the formation of policy in a democracy
28. NIH urged to involve the public in policy-making
29. Patients are important links in the healthcare chain
30. Patient accountability and quality of care: Lessons from medical consumerism and the patients’ rights, women’s health and disability rights movements
31. Building an effective doctor-patient relationship: From patient satisfaction to patient participation
32. The price of life
33. National policy development for the clinical application of genetic diagnostic technologies: Lessons from cystic fibrosis
34. The challenge of a lay partnership
35. Aknowledging the expertise of patients and their organisations
36. How do patients want physicians to handle mistakes? A survey or internal medicine patients in an academic setting